Rapid testing with molecular syndromic panels of patients presenting at the emergency department with pneumonia at risk for multidrug-resistant pathogens
Authors:
- Lorenzo PelagattiLPLorenzo Pelagatti
- Francesca ManganiFMFrancesca Mangani
- Elisa MuzEMElisa Muz
- Lorenzo CorbettaLCLorenzo Corbetta
- Sara TomassettiSTSara Tomassetti
- Alberto FareseAFAlberto Farese
- Alessandro BartoloniAlessandro Bartoloni
- Francesca CaldiFCFrancesca Caldi
- Mattia RonchettiMRMattia Ronchetti
- Tommaso GianiTommaso Giani
- Peiman NazerianPNPeiman Nazerian
- Gian Maria RossoliniGian Maria Rossolini
Open Access
- 10 December 2025
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 45 (3) , 863-875
Abstract
Background: Pneumonia remains a major cause of morbidity and mortality worldwide. Rapid diagnostic testing with molecular syndromic panels (MSP) has proved useful for the management of antimicrobial treatment of hospital-acquired pneumonia (HAP). In this study, we evaluated the impact of early use of MSP testing in the Emergency Department (ED) for the management of antibiotic therapy in patients with moderate to severe CAP with risk factors for multi-drug-resistant pathogens (CAP-MDR). Patients and methods: Patients presenting at the ED with diagnosis of moderate to severe CAP-MDR underwent microbiological analysis of lower respiratory tract specimens by culture and MSP testing (bioMérieux, FilmArray ® Pneumonia Plus Panel). The primary outcome was the percentage of cases in which MSP testing modified the empiric antimicrobial therapy started according to local protocols. Among the secondary outcomes we included the time elapsed from ED admission to antibiotic change or confirmation upon receipt of the MSP results. Results: Between June 2024 and May 2025, 93 patients were enrolled (age, 72.9 ± 13.9 years; 62.4% males). MSP testing identified one or more pathogens in 91.4% of cases. Modification of empiric antibiotic therapy, started according to local protocols, occurred in 65.6% of patients (escalation in 44.1% and de-escalation in 21.5% of cases) after 11.4 ± 6.3 h (IQR 12.0) since ED presentation. Conclusions: The early use of MSP on lower respiratory samples collected in the ED from patients with diagnosis of moderate to severe CAP-MDR could allow a rapid and targeted modification of the empiric antibiotic therapy in these patients, with potential advantages on antimicrobial stewardship and patient management.Keywords
Funding Information
- Università degli Studi di Firenze
This publication has 41 references indexed in Scilit:
- INHALE WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumoniaIntensive Care Medicine, 2025
- Rapid syndromic multiplex PCR panels for the management of ventilator-associated lower respiratory tract infections: pondering important limitations. Author’s replyIntensive Care Medicine, 2024
- Assessing the Utility of Multiplexed Polymerase Chain Reaction in Detecting Microorganisms Causing Infections in Critically ill PatientsCurrent Microbiology, 2023
- Performance evaluation of a PCR panel (FilmArray® Pneumonia Plus) for detection of respiratory bacterial pathogens in respiratory specimens: A systematic review and meta-analysisAnaesthesia Critical Care & Pain Medicine, 2023
- Multicentric evaluation of BioFire FilmArray Pneumonia Panel for rapid bacteriological documentation of pneumoniaClinical Microbiology and Infection, 2021
- An evaluation of the Unyvero pneumonia system for rapid detection of microorganisms and resistance markers of lower respiratory infections—a multicenter prospective study on ICU patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2021
- Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unitEuropean Journal of Clinical Microbiology & Infectious Diseases, 2021
- Comparison of Unyvero P55 Pneumonia Cartridge, in-house PCR and culture for the identification of respiratory pathogens and antibiotic resistance in bronchoalveolar lavage fluids in the critical care settingEuropean Journal of Clinical Microbiology & Infectious Diseases, 2019
- Burden of Adult Community-acquired, Health-care-Associated, Hospital-Acquired, and Ventilator-Associated PneumoniaChest, 2017
- Processes and Outcomes of Care for Patients With Community-Acquired PneumoniaArchives of internal medicine (1960), 1999